Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,957,000 | 3,815,000 | 8,530,000 | 7,310,000 | 11,117,000 |
| Marketable Securities | N/A | 4,140,000 | N/A | N/A | N/A |
| Receivables | 6,353,000 | 6,161,000 | 6,087,000 | 5,885,000 | 5,292,000 |
| Inventories | 4,982,000 | 4,498,000 | 4,610,000 | 4,690,000 | 3,926,000 |
| Other current assets | 3,042,000 | 2,790,000 | 1,746,000 | 1,910,000 | 1,580,000 |
| TOTAL | $21,334,000 | $21,404,000 | $20,973,000 | $19,795,000 | $21,915,000 |
| Non-Current Assets | |||||
| PPE Net | 11,265,000 | 10,945,000 | 10,241,000 | 10,077,000 | N/A |
| Investments And Advances | 0 | 6,111,000 | 0 | 0 | 0 |
| Intangibles | 21,335,000 | 21,230,000 | 21,706,000 | 21,594,000 | 0 |
| Other Non-Current Assets | 14,390,000 | 8,318,000 | 13,942,000 | 14,463,000 | 36,933,000 |
| TOTAL | $46,990,000 | $46,604,000 | $45,889,000 | $46,134,000 | $36,933,000 |
| Total Assets | $68,324,000 | $68,008,000 | $66,862,000 | $65,929,000 | $58,848,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,689,000 | 6,643,000 | 7,258,000 | 7,809,000 | 6,750,000 |
| Accounts payable and accrued liabilities | 2,575,000 | 2,487,000 | 2,113,000 | 2,196,000 | 1,936,000 |
| Other current liabilities | 8,103,000 | 5,736,000 | 6,944,000 | 6,752,000 | 6,904,000 |
| TOTAL | $17,549,000 | $16,234,000 | $16,315,000 | $16,757,000 | $15,590,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 661,000 | 656,000 | 1,963,000 | 1,617,000 | 1,344,000 |
| Other Non-Current Liabilities | 9,610,000 | 4,525,000 | 9,991,000 | 10,385,000 | 8,151,000 |
| TOTAL | $10,273,000 | $10,480,000 | $11,957,000 | $12,008,000 | $9,504,000 |
| Total Liabilities | $27,822,000 | $26,714,000 | $28,272,000 | $28,765,000 | $25,094,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 990,000 | N/A | N/A | N/A |
| Retained earnings | N/A | 40,261,000 | N/A | N/A | N/A |
| Other shareholders' equity | 40,502,000 | 183,000 | 38,590,000 | 37,164,000 | 33,754,000 |
| TOTAL | $40,502,000 | $41,294,000 | $38,590,000 | $37,164,000 | $33,754,000 |
| Total Liabilities And Equity | $68,324,000 | $68,008,000 | $66,862,000 | $65,929,000 | $58,848,000 |